LENZ Therapeutics, Inc.

Q3 2026 13F Holders

Symbol
LENZ
CUSIP
52635N103
Type
Equity
Class
COM
Num filings
25
Total reported value, excl. options
$900 k
Manager Report Date Value ($000) Shares Option Type